Skip to main content

Table 2 All treatments, deaths, and ocular preservations in survivors

From: Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma

DiseasePatientsTreatmentsNumber of PatientsDeathBinocular Survivors (%)
Trilateral-onset n = 1n = 1RT and Systemic chemotherapy11 (Pt 2)0(0%)
Bilateral-onset n = 38n = 38Enucleation and/or Local therapy alone501 / 5(25%)
  Enucleation and/or Local therapy with RT82 (Pt 3, Pt 6)2 / 6(33%)
  Systemic chemotherapy252 (Pt 5, Pt 1)0 / 8a(0%)
  with RT (and IAC)10 (1)22/ 15(13%)
  w/o RT (and IAC)15 (5)00(0%)
    4/38 (10.5%)5/38(13.2%)
Unilateral-onset n = 77n = 77Enucleation and/or Local therapy alone5200 / 52(0%)
  Enucleation and/or Local therapy with RT200 / 2(0%)
  Systemic chemotherapy231 (Pt 4)0 / 4(0%)
  with RT514 / 18(22%)
  w/o RT (and IAC)18 (4)00 / 52(0%)
    1/77 (1.3%)4/77(5.2%)
  1. aTwo survivors were blind due to binocular loss